The myth of the biotech revolution: An assessment of technological, clinical and organisational change-Reference-Cited by-同舟云学术

The myth of the biotech revolution: An assessment of technological, clinical and organisational change

Published:2007-05 Issue:4 Volume:36 Page:566-589
ISSN:0048-7333
Container-title:Research Policy
language:en
Short-container-title:Research Policy

Author:

Hopkins Michael M.,Martin Paul A.,Nightingale Paul,Kraft Alison,Mahdi Surya

Publisher

Elsevier BV

Subject

Management of Technology and Innovation,Management Science and Operations Research,Strategy and Management

Reference135 articles.

1. The Truth about Drug Companies;Angell,2004

2. Molecular Pharmacology, Medicinal Chemistry Series;Ariens,1964

3. Arnst, C., 2005. Biotech, finally. Business Week, 13 June, pp. 41–46.

4. Arundel, A., Mintzes, B., 2004. The impact of biotechnology on health. Merit-Innogen Working Paper. University of Edinburgh-Open University, Edinburgh and Bucks.

5. AstraZeneca, 2001. Annual Report and Form 20-F. Available from http://www2.astrazeneca.com/annualrep2001/default.asp.

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmaceutical productivity gap – Incremental decline in R&D efficiency despite transient improvements;Drug Discovery Today;2024-09

2. To integrate or not? Understanding knowledge integration of target firm;Cross Cultural & Strategic Management;2024-02-19

3. Gene therapies, uncertainty, and decision-making: thinking about the last mile at the first step;Expert Review of Pharmacoeconomics & Outcomes Research;2023-08-09

4. Technology acquisition following inventor exit in the biopharmaceutical industry;Technovation;2023-08

5. Cancer research and innovation: conceptualising a persistent anomaly;Innovation;2023-05-02